Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis. | Front Pharmacol | 2023 | 38239196 | PubTator, text mining | PubMed |
| Double Subclavian Steal Syndrome As Initial Manifestation of Erdheim-Chester Disease: A Case Report. | Cureus | 2023 | 38222166 | PubTator, text mining | PubMed |
| Clinical Application of the Association between Genetic Alteration and Intraoperative Fluorescence Activity of 5-Aminolevulinic Acid during the Resection of Brain Metastasis of Lung Adenocarcinoma. | Cancers (Basel) | 2023 | 38201516 | PubTator, text mining | PubMed |
| Identification of genes associated with gall bladder cell carcinogenesis: Implications in targeted therapy of gall bladder cancer. | World J Gastrointest Oncol | 2023 | 38173427 | PubTator, text mining | PubMed |
| Transcriptome Changes and Metabolic Outcomes After Bariatric Surgery in Adults With Obesity and Type 2 Diabetes. | J Endocr Soc | 2023 | 38162016 | PubTator, text mining | PubMed |
| The landscape of actionable genomic alterations in lung adenocarcinomas in India. | Front Genet | 2023 | 38155717 | PubTator, text mining | PubMed |
| Unveiling the domain-specific and RAS isoform-specific details of BRAF kinase regulation. | Elife | 2023 | 38150000 | PubTator, text mining | PubMed |
| Druggable genomic landscapes of high-grade gliomas. | Front Med (Lausanne) | 2023 | 38143440 | PubTator, text mining | PubMed |
| Prevalence of RAF1 Aberrations in Metastatic Cancer Patients: Real-World Data. | Biomedicines | 2023 | 38137485 | PubTator, text mining | PubMed |
| Work-Up and Treatment Strategies for Individuals with PIK3CA-Related Disorders: A Consensus of Experts from the Scientific Committee of the Italian Macrodactyly and PROS Association. | Genes (Basel) | 2023 | 38136956 | PubTator, text mining | PubMed |
| Spitz Tumors and Melanoma in the Genomic Age: A Retrospective Look at Ackerman's Conundrum. | Cancers (Basel) | 2023 | 38136379 | PubTator, text mining | PubMed |
| The Targeted Degradation of BRAF V600E Reveals the Mechanisms of Resistance to BRAF-Targeted Treatments in Colorectal Cancer Cells. | Cancers (Basel) | 2023 | 38136350 | PubTator, text mining | PubMed |
| Susceptibility Genes Associated with Multiple Primary Cancers. | Cancers (Basel) | 2023 | 38136334 | PubTator, text mining | PubMed |
| MicroRNA miR-212-5p Regulates the MEK/ERK Signaling Pathway by Targeting A-Raf proto-oncogene serine/threonine-protein kinase (ARAF) to Regulate Cowshed PM2.5-Induced NR8383 Apoptosis. | Toxics | 2023 | 38133382 | PubTator, text mining | PubMed |
| Targeting CRAF kinase in anti-cancer therapy: progress and opportunities. | Mol Cancer | 2023 | 38111008 | PubTator, text mining | PubMed |
| A Fluorescence-Based Sensor for Calibrated Measurement of Protein Kinase Stability in Live Cells. | bioRxiv | 2023 | 38106090 | PubTator, text mining | PubMed |
| Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. | Signal Transduct Target Ther | 2023 | 38105263 | PubTator, text mining | PubMed |
| Wild-type C-Raf gene dosage and dimerization drive prostate cancer metastasis. | iScience | 2023 | 38089570 | PubTator, text mining | PubMed |
| Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial. | Cell Rep Med | 2023 | 38086377 | PubTator, text mining | PubMed |
| Role of loss and skew of X chromosome inactivation for developing myelodysplastic syndrome in patients with Klinefelter syndrome: A brief review of the literature. | Leuk Res Rep | 2023 | 38076633 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=5